Skip to main content
Journal cover image

Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study.

Publication ,  Journal Article
Jorbendaze, A; Young, R; Shaburishvili, T; Demyanchuk, V; Buriak, R; Todurov, B; Rudenko, K; Zuber, M; Stämpfli, SF; Tanner, FC; Erne, P ...
Published in: ESC Heart Fail
August 2022

AIMS: Synchronized diaphragmatic stimulation (SDS) modulates intrathoracic and intra-abdominal pressures with favourable effects on cardiac function for patients with a reduced left ventricular ejection fraction (LVEF) and heart failure (HFrEF). VisONE-HF is a first-in-patient, observational study assessing the feasibility and 1 year effects of a novel, minimally invasive SDS device. METHODS AND RESULTS: The SDS system comprises a pulse generator and two laparoscopically delivered, bipolar, active-fixation leads on the inferior diaphragmatic surface. Fifteen symptomatic men with HFrEF and ischaemic heart disease receiving guideline-recommended therapy were enrolled (age 60 [56, 67] years, New York Heart Association class II [53%] /III [47%], LVEF 27 [23, 33] %, QRSd 117 [100, 125] ms, & N terminal pro brain natriuretic peptide [NT-proBNP] 1779 [911, 2,072] pg/mL). Implant success was 100%. Patients were evaluated at 3, 6, and 12 months for device-related or lead-related complications, quality of life (SF-36 QOL), 6 min hall walk distance (6MHWd), and by echocardiography. No implant procedure or SDS-related adverse event occurred, and patients were unaware of diaphragmatic stimulation. By 12 months, left ventricular end-systolic volume decreased (136 [123, 170] mL to 98 [89, 106] mL; P = 0.05), 6MHWd increased (315 [300, 330] m to 340 [315, 368] m; P = 0.004), and SF-36 QOL improved (physical scale 0 [0, 0] to 25 [0, 50], P = 0.006; emotional scale 0 [0, 33] to 33 [33, 67], P = 0.001). Although neither reached statistical significance, LVEF decreased (28 [23, 40]% vs. 34 [29, 38]%; P = ns) and NT-proBNP was lower (1784 [920, 2540] pg/mL vs. 1492 [879, 2028] pg/mL; P = ns). CONCLUSIONS: These data demonstrate the feasibility of laparoscopic implantation and delivery of SDS without raising safety concerns. These encouraging findings should be investigated further in adequately powered randomized trials.

Duke Scholars

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

August 2022

Volume

9

Issue

4

Start / End Page

2207 / 2214

Location

England

Related Subject Headings

  • Ventricular Function, Left
  • Stroke Volume
  • Quality of Life
  • Myocardial Ischemia
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jorbendaze, A., Young, R., Shaburishvili, T., Demyanchuk, V., Buriak, R., Todurov, B., … Cleland, J. G. F. (2022). Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study. ESC Heart Fail, 9(4), 2207–2214. https://doi.org/10.1002/ehf2.13984
Jorbendaze, Ana, Robin Young, Tamaz Shaburishvili, Vitaly Demyanchuk, Roman Buriak, Borys Todurov, Kostyantyn Rudenko, et al. “Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study.ESC Heart Fail 9, no. 4 (August 2022): 2207–14. https://doi.org/10.1002/ehf2.13984.
Jorbendaze A, Young R, Shaburishvili T, Demyanchuk V, Buriak R, Todurov B, et al. Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study. ESC Heart Fail. 2022 Aug;9(4):2207–14.
Jorbendaze, Ana, et al. “Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study.ESC Heart Fail, vol. 9, no. 4, Aug. 2022, pp. 2207–14. Pubmed, doi:10.1002/ehf2.13984.
Jorbendaze A, Young R, Shaburishvili T, Demyanchuk V, Buriak R, Todurov B, Rudenko K, Zuber M, Stämpfli SF, Tanner FC, Erne P, Mirro M, Fudim M, Goldberg LR, Cleland JGF. Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study. ESC Heart Fail. 2022 Aug;9(4):2207–2214.
Journal cover image

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

August 2022

Volume

9

Issue

4

Start / End Page

2207 / 2214

Location

England

Related Subject Headings

  • Ventricular Function, Left
  • Stroke Volume
  • Quality of Life
  • Myocardial Ischemia
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology